Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2015

Published: Oct, 2015 | Pages: 42 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2015', provides an overview of the Orchid Chemicals & Pharmaceuticals Ltd's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Orchid Chemicals & Pharmaceuticals Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Orchid Chemicals & Pharmaceuticals Ltd including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Orchid Chemicals & Pharmaceuticals Ltd's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Orchid Chemicals & Pharmaceuticals Ltd's pipeline products

Reasons to Buy

- Evaluate Orchid Chemicals & Pharmaceuticals Ltd's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Orchid Chemicals & Pharmaceuticals Ltd in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Orchid Chemicals & Pharmaceuticals Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Orchid Chemicals & Pharmaceuticals Ltd and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Orchid Chemicals & Pharmaceuticals Ltd
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of Orchid Chemicals & Pharmaceuticals Ltd and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents

Table of Contents
 2
List of Tables 5
List of Figures 5
Orchid Chemicals & Pharmaceuticals Ltd Snapshot 6
Orchid Chemicals & Pharmaceuticals Ltd Overview 6
Key Information 6
Key Facts 6
Orchid Chemicals & Pharmaceuticals Ltd - Research and Development Overview 7
Key Therapeutic Areas 7
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Out-Licensed Products 12
Out-Licensed Products/Combination Treatment Modalities 13
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products Glance 14
Orchid Chemicals & Pharmaceuticals Ltd - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
Orchid Chemicals & Pharmaceuticals Ltd - Drug Profiles 16
OCID-0050 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
OCID-2987 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
OCID-5005 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
OCID-5090 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Small Molecule 3 to Inhibit HDAC for Oncology 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Small Molecule to Inhibit Dipeptidyl-Peptidase IV for Type II Diabetes 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Small Molecule to Inhibit IL-6 and STAT3 for Oncology 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Small Molecule to Inhibit Th1/Th2 Cytokine Synthase for Inflammation 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Small Molecule to Inhibit TNF Alpha for Inflammation 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
tubastatin 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Small Molecule 1 to Inhibit HDAC for Oncology 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Small Molecule 2 to Inhibit HDAC for Oncology 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Small Molecule for Central Nervous System 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Small Molecule for Diabetes 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Small Molecule for Obesity 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Small Molecule to Antagonize ALK for Lung Cancer 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Small Molecule to Inhibit Penicillin-Binding Proteins for Bacterial Infections 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Small Molecules for Tuberculosis 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Analysis 34
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Target 34
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Route of Administration 35
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Molecule Type 36
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Mechanism of Action 37
Orchid Chemicals & Pharmaceuticals Ltd - Dormant Projects 38
Orchid Chemicals & Pharmaceuticals Ltd - Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Appendix 41
Methodology 41
Coverage 41
Secondary Research 41
Primary Research 41
Expert Panel Validation 41
Contact Us 41
Disclaimer 42

List of Tables

Orchid Chemicals & Pharmaceuticals Ltd, Key Information 6
Orchid Chemicals & Pharmaceuticals Ltd, Key Facts 6
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Indication, 2015 9
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Stage of Development, 2015 10
Orchid Chemicals & Pharmaceuticals Ltd - Monotherapy Products in Pipeline, 2015 11
Orchid Chemicals & Pharmaceuticals Ltd - Out-Licensed Products in Pipeline, 2015 12
Orchid Chemicals & Pharmaceuticals Ltd - Out-Licensed Products/ Combination Treatment Modalities, 2015 13
Orchid Chemicals & Pharmaceuticals Ltd - Preclinical, 2015 14
Orchid Chemicals & Pharmaceuticals Ltd - Discovery, 2015 15
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Target, 2015 34
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Route of Administration, 2015 35
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Molecule Type, 2015 36
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Mechanism of Action, 2015 37
Orchid Chemicals & Pharmaceuticals Ltd - Dormant Developmental Projects,2015 38
Orchid Chemicals & Pharmaceuticals Ltd, Other Locations 39
Orchid Chemicals & Pharmaceuticals Ltd, Subsidiaries 40